Cargando…
Update in treatment of uveitic macular edema
Macular edema (ME) represents the most common cause for visual loss among uveitis patients. The management of uveitic macular edema (UME) may be challenging, due to its often recalcitrant nature. Corticosteroids remain the mainstay of treatment, through their capability of effectively controlling in...
Autores principales: | Koronis, Spyridon, Stavrakas, Panagiotis, Balidis, Miltiadis, Kozeis, Nikolaos, Tranos, Paris G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387597/ https://www.ncbi.nlm.nih.gov/pubmed/30858697 http://dx.doi.org/10.2147/DDDT.S166092 |
Ejemplares similares
-
Update on the Management of Uveitic Macular Edema
por: Teper, Slawomir Jan
Publicado: (2021) -
Unaccompanied Clinic Visits: Practical Consequences of a Stressor
Imposed by the COVID-19 Pandemic
por: Tranos, Paris G, et al.
Publicado: (2021) -
Novel Sutureless Scleral Fixated IOL for Inadequate or Absent Capsular Support
por: Sidiropoulos, Georgios, et al.
Publicado: (2022) -
The Proteins of Keratoconus: a Literature Review Exploring Their Contribution to the Pathophysiology of the Disease
por: Loukovitis, Eleftherios, et al.
Publicado: (2019) -
Rare Persistent Corneal Infection by Phoma sp. - A Case Report
por: Adamopoulou, Aspasia, et al.
Publicado: (2019)